AAAAAA
Results:
1-14
|
Results: 14
Authors:
PALVIMAKI EP
MAJASUO H
KUOPPAMAKI M
MANNISTO PT
SYVALAHTI E
HIETALA J
Citation: Ep. Palvimaki et al., DERAMCICLANE, A PUTATIVE ANXIOLYTIC DRUG, IS A SEROTONIN 5-HT2C RECEPTOR INVERSE AGONIST BUT FAILS TO INDUCE 5-HT2C RECEPTOR DOWN-REGULATION, Psychopharmacology, 136(2), 1998, pp. 99-104
Authors:
TIIHONEN J
VILKMAN H
RASANEN P
RYYNANEN OP
HAKKO H
BERGMAN J
HAMALAINEN T
LAAKSO A
HAAPARANTASOLIN M
SOLIN O
KUOPPAMAKI M
SYVALAHTI E
HIETALA J
Citation: J. Tiihonen et al., STRIATAL PRESYNAPTIC DOPAMINE FUNCTION IN TYPE-1 ALCOHOLICS MEASURED WITH POSITRON-EMISSION-TOMOGRAPHY, Molecular psychiatry, 3(2), 1998, pp. 156-161
Authors:
HIETALA J
KUOPPAMAKI M
NAGREN K
LEHIKOINEN P
SYVALAHTI E
Citation: J. Hietala et al., EFFECTS OF LORAZEPAM ADMINISTRATION ON STRIATAL DOPAMINE D-2 RECEPTOR-BINDING CHARACTERISTICS IN MAN - A POSITRON EMISSION TOMOGRAPHY STUDY, Psychopharmacology, 132(4), 1997, pp. 361-365
Authors:
TIIHONEN J
KUOPPAMAKI M
NAGREN K
BERGMAN J
ERONEN E
SYVALAHTI E
HIETALA J
Citation: J. Tiihonen et al., SEROTONERGIC MODULATION OF STRIATAL D-2 DOPAMINE-RECEPTOR BINDING IN HUMANS MEASURED WITH POSITRON EMISSION TOMOGRAPHY, Psychopharmacology, 126(4), 1996, pp. 277-280
Authors:
PALVIMAKI EP
ROTH BL
MAJASUO H
LAAKSO A
KUOPPAMAKI M
SYVALAHTI E
HIETALA J
Citation: Ep. Palvimaki et al., INTERACTIONS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS WITH THE SEROTONIN 5-HT2C RECEPTOR, Psychopharmacology, 126(3), 1996, pp. 234-240
Authors:
LAAKSO A
PALVIMAKI EP
KUOPPAMAKI M
SYVALAHTI E
HIETALA J
Citation: A. Laakso et al., CHRONIC CITALOPRAM AND FLUOXETINE TREATMENTS UP-REGULATE 5-HT2C RECEPTORS IN THE RAT CHOROID-PLEXUS, Neuropsychopharmacology, 15(2), 1996, pp. 143-151
Authors:
WONG G
KUOPPAMAKI M
HIETALA J
LUDDENS H
SYVALAHTI E
KORPI ER
Citation: G. Wong et al., EFFECTS OF CLOZAPINE METABOLITES AND CHRONIC CLOZAPINE TREATMENT ON RAT-BRAIN GABA(A) RECEPTORS, European journal of pharmacology, 314(3), 1996, pp. 319-323
Authors:
KUOPPAMAKI M
PALVIMAKI EP
HIETALA J
SYVALAHTI E
Citation: M. Kuoppamaki et al., DIFFERENTIAL REGULATION OF RAT 5-HT2A AND 5-HT2C RECEPTORS AFTER CHRONIC TREATMENT WITH CLOZAPINE, CHLORPROMAZINE AND 3 PUTATIVE ATYPICAL ANTIPSYCHOTIC-DRUGS, Neuropsychopharmacology, 13(2), 1995, pp. 139-150
Authors:
HIETALA J
SYVALAHTI E
VUORIO K
RAKKOLAINEN V
BERGMAN J
HAAPARANTA M
SOLIN O
KUOPPAMAKI M
KIRVELA O
RUOTSALAINEN U
SALOKANGAS RKR
Citation: J. Hietala et al., PRESYNAPTIC DOPAMINE FUNCTION IN STRIATUM OF NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS, Lancet, 346(8983), 1995, pp. 1130-1131
Authors:
PALVIMAKI EP
LAAKSO A
KUOPPAMAKI M
SYVALAHTI E
HIETALA J
Citation: Ep. Palvimaki et al., UP-REGULATION OF BETA(1)-ADRENERGIC RECEPTORS IN RAT-BRAIN AFTER CHRONIC CITALOPRAM AND FLUOXETINE TREATMENTS, Psychopharmacology, 115(4), 1994, pp. 543-546
Authors:
KUOPPAMAKI M
SEPPALA T
SYVALAHTI E
HIETALA J
Citation: M. Kuoppamaki et al., REGULATION OF SEROTONIN 5-HT2C RECEPTORS IN THE RAT CHOROID-PLEXUS AFTER ACUTE CLOZAPINE TREATMENT, European journal of pharmacology. Molecular pharmacology section, 269(2), 1994, pp. 201-208
Authors:
SYVALAHTI EKG
POHJALAINEN T
KORPI ER
PALVIMAKI EP
OVASKA T
KUOPPAMAKI M
HIETALA J
Citation: Ekg. Syvalahti et al., DOPAMINE D-2 RECEPTOR GENE-EXPRESSION IN RAT LINES SELECTED FOR DIFFERENCES IN VOLUNTARY ALCOHOL-CONSUMPTION, Alcoholism, clinical and experimental research, 18(4), 1994, pp. 1029-1031
Authors:
KUOPPAMAKI M
PALVIMAKI EP
SYVALAHTI E
HIETALA J
Citation: M. Kuoppamaki et al., 5-HT1C RECEPTOR-MEDIATED PHOSPHOINOSITIDE HYDROLYSIS IN THE RAT CHOROID-PLEXUS AFTER CHRONIC TREATMENT WITH CLOZAPINE, European journal of pharmacology, 255(1-3), 1994, pp. 91-97
Authors:
KUOPPAMAKI M
SYVALAHTI E
HIETALA J
Citation: M. Kuoppamaki et al., CLOZAPINE AND N-DESMETHYLCLOZAPINE ARE POTENT 5-HT(1C) RECEPTOR ANTAGONISTS, European journal of pharmacology. Molecular pharmacology section, 245(2), 1993, pp. 179-182
Risultati:
1-14
|